Second cancer after additive chemotherapy in patients with colon cancer: original study
Background - Additive chemotherapeutic treatment of UICC-stage -III / IV colon cancer with fluorouracil, leucovorin and oxaliplatin is widely accepted as current standard of treatment after R0-resection. However, as patients.. survival is increasing, long-term side effects of chemotherapeutic agents...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
29 November 2022
|
| In: |
Clinical colorectal cancer and other gastrointestinal malignancies
Year: 2022, Volume: 21, Issue: 4, Pages: 354-361 |
| ISSN: | 1938-0674 |
| DOI: | 10.1016/j.clcc.2022.07.002 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.clcc.2022.07.002 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1533002822000706 
|
| Author Notes: | Andreas Teufel, Moying Li, Michael Gerken, Matthias P. Ebert, Hans J Schlitt, Matthias Evert, Wolfgang Herr, Monika Klinkhammer-Schalke |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 185101618X | ||
| 003 | DE-627 | ||
| 005 | 20230706222403.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230626s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clcc.2022.07.002 |2 doi | |
| 035 | |a (DE-627)185101618X | ||
| 035 | |a (DE-599)KXP185101618X | ||
| 035 | |a (OCoLC)1389533422 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Teufel, Andreas |d 1971- |e VerfasserIn |0 (DE-588)121120031 |0 (DE-627)081100035 |0 (DE-576)292546750 |4 aut | |
| 245 | 1 | 0 | |a Second cancer after additive chemotherapy in patients with colon cancer |b original study |c Andreas Teufel, Moying Li, Michael Gerken, Matthias P. Ebert, Hans J Schlitt, Matthias Evert, Wolfgang Herr, Monika Klinkhammer-Schalke |
| 264 | 1 | |c 29 November 2022 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 16 July 2022, Artikelversion: 29 November 2022 | ||
| 500 | |a Gesehen am 26.06.2023 | ||
| 520 | |a Background - Additive chemotherapeutic treatment of UICC-stage -III / IV colon cancer with fluorouracil, leucovorin and oxaliplatin is widely accepted as current standard of treatment after R0-resection. However, as patients.. survival is increasing, long-term side effects of chemotherapeutic agents such as second cancer development are becoming increasingly important. - Patients - We therefore investigated a total of 2 856 Patients with UICC-stage III / IV colon cancer, 223 of whom (7.8%) had developed a subsequent second cancer. - Results - Median follow-up was 73.2 months (range 209.9 months, 95%-CI 69.8-76.9). Most frequent second cancers were prostate cancer (18.4%), colon cancer (16.1%), breast cancers (8.1%), lung cancer (8.1%), rectal cancer (4.9%) and uterine cancer (4.9%). However, in comparison to non-treated patients this did not represent a significantly increased risk for subsequent second cancer in patients after treatment with additive chemotherapy. Of interest, our data suggest a significantly decreased second cancer rate in patients treated with FOLFOX compared to FUFOL for additive treatment. - Conclusions - Second cancer development was not increased after additive chemotherapy for colon cancer, which is a novel aspect in the ongoing discussions on reduction of adjuvant treatment to 3 months or treatment of lymph node negative patients. Novelty and Impact Statement To our knowledge, this is the first population-based study analyzing second cancer development after additive chemotherapy in patients with UICC III-IV colon cancer. The results have an important impact on the surveillance and long-term follow-up of cancer patients. | ||
| 650 | 4 | |a 5-FU | |
| 650 | 4 | |a Adjuvant chemotherapy | |
| 650 | 4 | |a Adverse event | |
| 650 | 4 | |a Cancer registry | |
| 650 | 4 | |a oxaliplatin | |
| 700 | 1 | |a Li, Moying |d 1990- |e VerfasserIn |0 (DE-588)1188478036 |0 (DE-627)1667446290 |4 aut | |
| 700 | 1 | |a Gerken, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ebert, Matthias |d 1968- |e VerfasserIn |0 (DE-588)1030133522 |0 (DE-627)734827083 |0 (DE-576)377938432 |4 aut | |
| 700 | 1 | |a Schlitt, Hans J |e VerfasserIn |4 aut | |
| 700 | 1 | |a Evert, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Herr, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klinkhammer-Schalke, Monika |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical colorectal cancer and other gastrointestinal malignancies |d New York, NY [u.a.] : Elsevier, 2009 |g 21(2022), 4 vom: Dez., Seite 354-361 |h Online-Ressource |w (DE-627)635135388 |w (DE-600)2572502-6 |w (DE-576)428284140 |x 1938-0674 |7 nnas |a Second cancer after additive chemotherapy in patients with colon cancer original study |
| 773 | 1 | 8 | |g volume:21 |g year:2022 |g number:4 |g month:12 |g pages:354-361 |g extent:8 |a Second cancer after additive chemotherapy in patients with colon cancer original study |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.clcc.2022.07.002 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1533002822000706 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230626 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1030133522 |a Ebert, Matthias |m 1030133522:Ebert, Matthias |d 60000 |d 61100 |e 60000PE1030133522 |e 61100PE1030133522 |k 0/60000/ |k 1/60000/61100/ |p 4 | ||
| 998 | |g 1188478036 |a Li, Moying |m 1188478036:Li, Moying |d 60000 |d 61100 |e 60000PL1188478036 |e 61100PL1188478036 |k 0/60000/ |k 1/60000/61100/ |p 2 | ||
| 998 | |g 121120031 |a Teufel, Andreas |m 121120031:Teufel, Andreas |d 60000 |d 61100 |e 60000PT121120031 |e 61100PT121120031 |k 0/60000/ |k 1/60000/61100/ |p 1 |x j | ||
| 999 | |a KXP-PPN185101618X |e 4343749835 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"physDesc":[{"extent":"8 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Second cancer after additive chemotherapy in patients with colon cancer","title":"Second cancer after additive chemotherapy in patients with colon cancer","subtitle":"original study"}],"person":[{"family":"Teufel","role":"aut","given":"Andreas","display":"Teufel, Andreas"},{"family":"Li","role":"aut","given":"Moying","display":"Li, Moying"},{"family":"Gerken","role":"aut","given":"Michael","display":"Gerken, Michael"},{"role":"aut","given":"Matthias","family":"Ebert","display":"Ebert, Matthias"},{"given":"Hans J","role":"aut","family":"Schlitt","display":"Schlitt, Hans J"},{"display":"Evert, Matthias","given":"Matthias","role":"aut","family":"Evert"},{"role":"aut","given":"Wolfgang","family":"Herr","display":"Herr, Wolfgang"},{"given":"Monika","role":"aut","family":"Klinkhammer-Schalke","display":"Klinkhammer-Schalke, Monika"}],"recId":"185101618X","name":{"displayForm":["Andreas Teufel, Moying Li, Michael Gerken, Matthias P. Ebert, Hans J Schlitt, Matthias Evert, Wolfgang Herr, Monika Klinkhammer-Schalke"]},"origin":[{"dateIssuedDisp":"29 November 2022","dateIssuedKey":"2022"}],"id":{"eki":["185101618X"],"doi":["10.1016/j.clcc.2022.07.002"]},"note":["Online verfügbar: 16 July 2022, Artikelversion: 29 November 2022","Gesehen am 26.06.2023"],"relHost":[{"title":[{"title_sort":"Clinical colorectal cancer and other gastrointestinal malignancies","title":"Clinical colorectal cancer and other gastrointestinal malignancies"}],"titleAlt":[{"title":"Clinical colorectal cancer"},{"title":"Colorectal cancer"}],"note":["Gesehen am 04.02.2020"],"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["8.2009,4 -"],"language":["eng"],"origin":[{"dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisher":"Elsevier ; CIG Media Group","publisherPlace":"New York, NY [u.a.] ; Dallas, Tex."}],"id":{"eki":["635135388"],"zdb":["2572502-6"],"issn":["1938-0674"]},"part":{"text":"21(2022), 4 vom: Dez., Seite 354-361","extent":"8","pages":"354-361","volume":"21","issue":"4","year":"2022"},"recId":"635135388","disp":"Second cancer after additive chemotherapy in patients with colon cancer original studyClinical colorectal cancer and other gastrointestinal malignancies"}]} | ||
| SRT | |a TEUFELANDRSECONDCANC2920 | ||